Immuneering to Participate in September Investor Conferences

NEXT STORY
MacroGenics to Participate in Upcoming Investor Conferences
PREV STORY
Fate Therapeutics to Present at Upcoming Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Kalytera Receives IRB Approval for Proposed Phase 2 Study Evaluating CBD in the Prevention of Graft versus Host Disease

SAN FRANCISCO, Calif. and TEL AVIV, Israel, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Kalytera ...

author_avatar
NASDAQ Market News

Selecta Biosciences Announces Date of Second Quarter 2018 Financial Results Conference Call

WATERTOWN, Mass., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB), a ...

author_avatar
NASDAQ Market News

BeiGene to Participate in Goldman Sachs 37th Annual Global Healthcare Conference

WALTHAM, Mass., June 06, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (Nasdaq:BGNE), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News